Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Digestive Diseases and Sciences
Erschienen in: Digestive Diseases and Sciences 8/2018

09.06.2018 | Review

Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett’s Stemming from SPEM

verfasst von: Ramon U. Jin, Jason C. Mills

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Chronic injury and inflammation in the esophagus can cause a change in cellular differentiation known as metaplasia. Most commonly, the differentiation changes manifest as Barrett’s esophagus (BE), characterized by the normal stratified squamous epithelium converting into a cuboidal–columnar, glandular morphology. BE cells can phenotypically resemble specific normal cell types of the stomach or intestine, or they can have overlapping phenotypes in disorganized admixtures. The stomach can also undergo metaplasia characterized by aberrant gastric or intestinal differentiation patterns. In both organs, it has been argued that metaplasia may represent a recapitulation of the embryonic or juvenile gastrointestinal tract, as cells access a developmental progenitor genetic program that can help repair damaged tissue. Here, we review the normal development of esophagus and stomach, and describe how BE represents an intermixing of cells resembling gastric pseudopyloric (SPEM) and intestinal metaplasia. We discuss a cellular process recently termed “paligenosis” that governs how mature, differentiated cells can revert to a proliferating progenitor state in metaplasia. We discuss the “Cyclical Hit” theory in which paligenosis might be involved in the increased risk of metaplasia for progression to cancer. However, somatic mutations might occur in proliferative phases and then be warehoused upon redifferentiation. Through years of chronic injury and many rounds of paligenosis and dedifferentiation, eventually a cell with a mutation that prevents dedifferentiation may arise and clonally expand fueling stable metaplasia and potentially thereafter acquiring additional mutations and progressing to dysplasia and cancer.
Literatur
1.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.PubMedCrossRef
2.
3.
4.
Virchow RK. Ueber Metaplasie: Vortrag, gehalten auf dem internationalen medicinischen Congress in Kopenhagen. Berlin: Georg Reimer; 1884.
5.
6.
7.
8.
Adami JG. On growth and overgrowth and on the relationship between cell differentiation and proliferative capacity; its bearing upon the regeneration of tissues and the development of tumors. In: “Festschrift” in Honor of Abraham Jacobi. New York: The Knickerbocker Press; 1900.
9.
Delafield F, Prudden TM, Wood FC. Delafield and Prudden’s Text-Book of Pathology. 16th ed. Baltimore: W. Wood & Company; 1936.
10.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676.PubMedCrossRef
11.
Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872.PubMedCrossRef
12.
Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313–317.PubMedCrossRef
13.
Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322:949–953.PubMedCrossRef
14.
Schmidt PH, Lee JR, Joshi V, et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest. 1999;79:639–646.PubMed
15.
16.
Goldenring JR, Nam KT, Mills JC. The origin of pre-neoplastic metaplasia in the stomach: chief cells emerge from the Mist. Exp Cell Res. 2011;317:2759–2764.PubMedPubMedCentralCrossRef
17.
Petersen CP, Mills JC, Goldenring JR. Murine models of gastric corpus preneoplasia. Cell Mol Gastroenterol Hepatol. 2017;3:11–26.PubMedCrossRef
18.
Weis VG, Goldenring JR. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer. 2009;12:189–197.PubMedCrossRef
19.
Saenz JB, Mills JC. Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol. 2018;15:257–273.PubMedCrossRef
20.
Huh WJ, Khurana SS, Geahlen JH, Kohli K, Waller RA, Mills JC. Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach. Gastroenterology. 2012;142:21–24.PubMedCrossRef
21.
Saenz JB, Burclaff J, Mills JC. Modeling murine gastric metaplasia through tamoxifen-induced acute parietal cell loss. Methods Mol Biol. 2016;1422:329–339.PubMedPubMedCentralCrossRef
22.
Goldenring JR, Ray GS, Coffey RJ, et al. Reversible drug-induced oxyntic atrophy in rats. Gastroenterology. 2000;118:1080–1093.PubMedCrossRef
23.
Nomura S, Yamaguchi H, Ogawa M, Wang TC, Lee JR, Goldenring JR. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2005;288:G362–G375.PubMedCrossRef
24.
Weis VG, Sousa JF, LaFleur BJ, et al. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression. Gut. 2013;62:1270–1279.PubMedCrossRef
25.
Leushacke M, Tan SH, Wong A, et al. Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach. Nat Cell Biol. 2017;19:774–786.PubMedCrossRef
26.
Nam KT, Lee HJ, Sousa JF, et al. Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology. 2010;139:2028–2037.PubMedPubMedCentralCrossRef
27.
Weis VG, Petersen CP, Weis JA, et al. Maturity and age influence chief cell ability to transdifferentiate into metaplasia. Am J Physiol Gastrointest Liver Physiol. 2017;312:G67–G76.PubMedCrossRef
28.
Capoccia BJ, Jin RU, Kong YY, et al. The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. J Clin Invest. 2013;123:1475–1491.PubMedPubMedCentralCrossRef
29.
Lennerz JK, Kim SH, Oates EL, et al. The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. Am J Pathol. 2010;177:1514–1533.PubMedPubMedCentralCrossRef
30.
31.
Radyk MD, Burclaff J, Willet SG, Mills JC. Metaplastic cells in the stomach arise, independently of stem cells, via dedifferentiation or transdifferentiation of chief cells. Gastroenterology. 2017;154:257–273.
32.
Hayakawa Y, Fox JG, Wang TC. Isthmus stem cells are the origins of metaplasia in the gastric corpus. Cell Mol Gastroenterol Hepatol. 2017;4:89–94.PubMedPubMedCentralCrossRef
33.
Hayakawa Y, Ariyama H, Stancikova Y, et al. Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche. Cancer Cell. 2015;28:800–814.PubMedPubMedCentralCrossRef
34.
Kinoshita H, Hayakawa Y, Niu Z, et al. Mature gastric chief cells are not required for the development of metaplasia. Am J Physiol Gastrointest Liver Physiol. 2018;314:G583–G596.PubMedCrossRef
35.
Blaine SA, Ray KC, Anunobi R, Gannon MA, Washington MK, Means AL. Adult pancreatic acinar cells give rise to ducts but not endocrine cells in response to growth factor signaling. Development. 2010;137:2289–2296.PubMedPubMedCentralCrossRef
36.
Mills JC. Sansom OJ (2015) Reserve stem cells: differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract. Sci Signal. 2015;8(385):re8.PubMedPubMedCentralCrossRef
37.
De La OJ, Emerson JP, Goodman JL, et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A. 2008;105:18907–18912.CrossRef
38.
Habbe N, Shi G, Meguid RA, et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A. 2008;105:18913–18918.PubMedPubMedCentralCrossRef
39.
Houbracken I, de Waele E, Lardon J, et al. Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas. Gastroenterology. 2011;141:731–741.PubMedCrossRef
40.
Morris JP, Cano DA, Sekine S, Wang SC, Hebrok M. β-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J Clin Invest. 2010;120:508–520.PubMedPubMedCentralCrossRef
41.
Pinho AV, Rooman I, Reichert M, et al. Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis. Gut. 2011;60:958–966.PubMedCrossRef
42.
Mainardi S, Mijimolle N, Francoz S, Vicente-Dueñas C, Sánchez-García I, Barbacid M. Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma. Proc Natl Acad Sci U S A. 2014;111:255–260.PubMedCrossRef
43.
Xu X, Rock JR, Lu Y, et al. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc Natl Acad Sci U S A. 2012;109:4910–4915.PubMedPubMedCentralCrossRef
44.
Sutherland KD, Proost N, Brouns I, Adriaensen D, Song JY, Berns A. Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. Cancer Cell. 2011;19:754–764.PubMedCrossRef
45.
Sutherland KD, Song JY, Kwon MC, Proost N, Zevenhoven J, Berns A. Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma. Proc Natl Acad Sci U S A. 2014;111:4952–4957.PubMedPubMedCentralCrossRef
46.
47.
Song H, Yao E, Lin C, Gacayan R, Chen MH, Chuang PT. Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesis. Proc Natl Acad Sci U S A. 2012;109:17531–17536.PubMedPubMedCentralCrossRef
48.
Willet SG, Lewis MA, Miao ZF et al., Regenerative proliferation of differentiated cells by mTORC1-dependent paligenosis. EMBO J. 2018.
49.
Adami JG. On growth and overgrowth and on the relationship between cell differentiation and proliferative capacity: its bearing upon the regeneration of tissues and the development of tumours. Manchester: Sherratt & Hughes; 1900.
50.
Guerra C, Schuhmacher AJ, Cañamero M, et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell. 2007;11:291–302.PubMedCrossRef
51.
Carriere C, Young AL, Gunn JR, Longnecker DS, Korc M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem Biophys Res Commun. 2009;382:561–565.PubMedPubMedCentralCrossRef
52.
Morris JPT, Wang SC, Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer. 2010;10:683–695.PubMedPubMedCentralCrossRef
53.
Krah NM, De La OJP, Swift GH, et al. The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. Elife. 2015;4:e07125.PubMedCentralCrossRef
54.
Collins MA, Bednar F, Zhang Y, et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest. 2012;122:639–653.PubMedPubMedCentralCrossRef
55.
Cooper CS, Eeles R, Wedge DC, et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat Genet. 2015;47:367–372.PubMedPubMedCentralCrossRef
56.
Forsberg LA, Rasi C, Pekar G, et al. Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer. Genome Res. 2015;25:1521–1535.PubMedPubMedCentralCrossRef
57.
Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9–22.PubMedCrossRef
58.
Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541:169–175.CrossRef
59.
Contino G, Vaughan TL, Whiteman D, Fitzgerald RC. The evolving genomic landscape of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2017;153:657–673.PubMedPubMedCentralCrossRef
60.
Gilbert SF, Barresi MJF. Developmental Biology. 11th ed. Sunderland: Sinauer Associates Inc; 2016.
61.
Yu WY, Slack JM, Tosh D. Conversion of columnar to stratified squamous epithelium in the developing mouse oesophagus. Dev Biol. 2005;284:157–170.PubMedCrossRef
62.
Rosekrans SL, Baan B, Muncan V, van den Brink GR. Esophageal development and epithelial homeostasis. Am J Physiol Gastrointest Liver Physiol. 2015;309:G216–G228.PubMedCrossRef
63.
64.
Que J, Okubo T, Goldenring JR, et al. Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development. 2007;134:2521–2531.PubMedPubMedCentralCrossRef
65.
Daniely Y, Liao G, Dixon G, et al. Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium. Am J Physiol Cell Physiol. 2004;287:C171–C181.PubMedCrossRef
66.
Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398:714–718.PubMedCrossRef
67.
Arnold K, Sarkar A, Yram MA, et al. Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell. 2011;9:317–329.PubMedPubMedCentralCrossRef
68.
Jeong Y, Rhee H, Martin S, et al. Identification and genetic manipulation of human and mouse oesophageal stem cells. Gut. 2016;65:1077–1086.PubMedCrossRef
69.
Liu K, Jiang M, Lu Y, et al. Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell. 2013;12:304–315.PubMedPubMedCentralCrossRef
70.
Wang Z, Dollé P, Cardoso WV, Niederreither K. Retinoic acid regulates morphogenesis and patterning of posterior foregut derivatives. Dev Biol. 2006;297:433–445.PubMedCrossRef
71.
Litingtung Y, Lei L, Westphal H, Chiang C. Sonic hedgehog is essential to foregut development. Nat Genet. 1998;20:58–61.PubMedCrossRef
72.
van Dop WA, Rosekrans SL, Uhmann A, et al. Hedgehog signalling stimulates precursor cell accumulation and impairs epithelial maturation in the murine oesophagus. Gut. 2013;62:348–357.PubMedCrossRef
73.
Li Y, Gordon J, Manley NR, Litingtung Y, Chiang C. Bmp4 is required for tracheal formation: a novel mouse model for tracheal agenesis. Dev Biol. 2008;322:145–155.PubMedPubMedCentralCrossRef
74.
Wang DH, Clemons NJ, Miyashita T, et al. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett’s metaplasia. Gastroenterology. 2010;138:1810–1822.PubMedPubMedCentralCrossRef
75.
Que J, Choi M, Ziel JW, Klingensmith J, Hogan BL. Morphogenesis of the trachea and esophagus: current players and new roles for noggin and Bmps. Differentiation. 2006;74:422–437.PubMedCrossRef
76.
Rodriguez P, Da Silva S, Oxburgh L, Wang F, Hogan BL, Que J. BMP signaling in the development of the mouse esophagus and forestomach. Development. 2010;137:4171–4176.PubMedPubMedCentralCrossRef
77.
Jiang M, Ku WY, Zhou Z, et al. BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis. J Clin Invest. 2015;125:1557–1568.PubMedPubMedCentralCrossRef
78.
Woo J, Miletich I, Kim BM, Sharpe PT, Shivdasani RA. Barx1-mediated inhibition of Wnt signaling in the mouse thoracic foregut controls tracheo-esophageal septation and epithelial differentiation. PLoS One. 2011;6:e22493.PubMedPubMedCentralCrossRef
79.
Kim BM, Miletich I, Mao J, McMahon AP, Sharpe PA, Shivdasani RA. Independent functions and mechanisms for homeobox gene Barx1 in patterning mouse stomach and spleen. Development. 2007;134:3603–3613.PubMedCrossRef
80.
81.
Ohashi S, Natsuizaka M, Yashiro-Ohtani Y, et al. NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network. Gastroenterology. 2010;139:2113–2123.PubMedPubMedCentralCrossRef
82.
Chen X, Qin R, Liu B, et al. Multilayered epithelium in a rat model and human Barrett’s esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol. 2008;8:1.PubMedPubMedCentralCrossRef
83.
van Olphen S, Biermann K, Spaander MC, et al. SOX2 as a novel marker to predict neoplastic progression in Barrett’s esophagus. Am J Gastroenterol. 2015;110:1420–1428.PubMedCrossRef
84.
Raghoebir L, Bakker ER, Mills JC, et al. SOX2 redirects the developmental fate of the intestinal epithelium toward a premature gastric phenotype. J Mol Cell Biol. 2012;4:377–385.PubMedPubMedCentralCrossRef
85.
86.
Roman S, Pétré A, Thépot A, et al. Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture. Am J Physiol Gastrointest Liver Physiol. 2007;293:G45–G53.PubMedCrossRef
87.
Hall PA, Woodman AC, Campbell SJ, Shepherd NA. Expression of the p53 homologue p63alpha and ΔNp63alpha in the neoplastic sequence of Barrett’s oesophagus: correlation with morphology and p53 protein. Gut. 2001;49:618–623.PubMedPubMedCentralCrossRef
88.
Geddert H, Kiel S, Heep HJ, Gabbert HE, Sarbia M. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Hum Pathol. 2003;34:850–856.PubMedCrossRef
89.
Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol. 2001;32:1157–1165.PubMedCrossRef
90.
Blache P, Van de Wetering M, Duluc I, et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol. 2004;166:37–47.PubMedPubMedCentralCrossRef
91.
Prevot PP, Simion A, Grimont A, et al. Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia. Gut. 2012;61:1723–1732.PubMedPubMedCentralCrossRef
92.
Grimont A, Pinho AV, Cowley MJ, et al. SOX9 regulates ERBB signalling in pancreatic cancer development. Gut. 2015;64:1790–1799.PubMedCrossRef
93.
Roche KC, Gracz AD, Liu XF, Newton V, Akiyama H, Magness ST. SOX9 maintains reserve stem cells and preserves radioresistance in mouse small intestine. Gastroenterology. 2015;149:1553–1563.PubMedPubMedCentralCrossRef
94.
Sashikawa Kimura M, Mutoh H, Sugano K. SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. J Gastroenterol. 2011;46:1292–1299.PubMedCrossRef
95.
Clemons NJ, Wang DH, Croagh D, et al. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett’s esophagus. Am J Physiol Gastrointest Liver Physiol. 2012;303:G1335–G1346.PubMedCrossRef
96.
Moore BD, Khurana SS, Huh WJ, Mills JC. Hepatocyte nuclear factor 4alpha is required for cell differentiation and homeostasis in the adult mouse gastric epithelium. Am J Physiol Gastrointest Liver Physiol. 2016;311:G267–G275.PubMedPubMedCentralCrossRef
97.
Babeu JP, Darsigny M, Lussier CR, Boudreau F. Hepatocyte nuclear factor 4alpha contributes to an intestinal epithelial phenotype in vitro and plays a partial role in mouse intestinal epithelium differentiation. Am J Physiol Gastrointest Liver Physiol. 2009;297:G124–G134.PubMedCrossRef
98.
Garrison WD, Battle MA, Yang C, Kaestner KH, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4α is essential for embryonic development of the mouse colon. Gastroenterology. 2006;130:1207–1220.PubMedPubMedCentralCrossRef
99.
Cattin AL, Le Beyec J, Barreau F, et al. Hepatocyte nuclear factor 4α, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol Cell Biol. 2009;29:6294–6308.PubMedPubMedCentralCrossRef
100.
Colleypriest BJ, Burke ZD, Griffiths LP, et al. Hnf4α is a key gene that can generate columnar metaplasia in oesophageal epithelium. Differentiation. 2017;93:39–49.PubMedPubMedCentralCrossRef
101.
Duggan SP, Behan FM, Kirca M, et al. The characterization of an intestine-like genomic signature maintained during Barrett’s-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival. Sci Rep. 2016;6:32638.PubMedPubMedCentralCrossRef
102.
Haveri H, Westerholm-Ormio M, Lindfors K, et al. Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa. BMC Gastroenterol. 2008;8:9.PubMedPubMedCentralCrossRef
103.
Thompson C, Kohlnhofer B, Stavniichuk R, et al. GATA4 regulates development of the squamocolumnar junction in the GI tract: implications for Barrett’s esophagus. Gastroenterology. 2017;152:S87.CrossRef
104.
Silberg DG, Swain GP, Suh ER, Traber PG. Cdx1 and cdx2 expression during intestinal development. Gastroenterology. 2000;119:961–971.PubMedCrossRef
105.
106.
Almeida R, Silva E, Santos‐Silva F, et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol. 2003;199:36–40.PubMedCrossRef
107.
Silberg DG, Furth EE, Taylor JK, et al. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology. 1997;113:478–486.PubMedCrossRef
108.
Silberg DG, Sullivan J, Kang E, et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 2002;122:689–696.PubMedCrossRef
109.
Stairs DB, Kong J, Lynch JP. Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia. Prog Mol Biol Transl Sci. 2010;96:231–270.PubMedPubMedCentralCrossRef
110.
Groisman GM, Amar M, Meir A. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett’s) metaplasia. Mod Pathol. 2004;17:1282–1288.PubMedCrossRef
111.
Wong NA, Wilding J, Bartlett S, et al. CDX1 is an important molecular mediator of Barrett’s metaplasia. Proc Natl Acad Sci U S A. 2005;102:7565–7570.PubMedPubMedCentralCrossRef
112.
Phillips RW, Frierson HF Jr, Moskaluk CA. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol. 2003;27:1442–1447.PubMedCrossRef
113.
Kazumori H, Ishihara S, Kinoshita Y. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett’s epithelium development. Gut. 2009;58:620–628.PubMedCrossRef
114.
Kazumori H, Ishihara S, Rumi MA, Kadowaki Y, Kinoshita Y. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett’s epithelium. Gut. 2006;55:16–25.PubMedPubMedCentralCrossRef
115.
Huo X, Zhang HY, Zhang XI, et al. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett’s esophagus. Gastroenterology. 2010;139:194–203.PubMedPubMedCentralCrossRef
116.
Marchetti M, Caliot E, Pringault E. Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. J Cell Sci. 2003;116:1429–1436.PubMedCrossRef
117.
Quante M, Bhagat G, Abrams JA, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell. 2012;21:36–51.PubMedPubMedCentralCrossRef
118.
119.
Minacapelli CD, Bajpai M, Geng X, et al. Barrett’s metaplasia develops from cellular reprogramming of esophageal squamous epithelium due to gastroesophageal reflux. Am J Physiol Gastrointest Liver Physiol. 2017;312:G615–G622.PubMedCrossRef
120.
Mari L, Milano F, Parikh K, et al. A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia. Cell Rep. 2014;7:1197–1210.PubMedCrossRef
121.
Kong J, Crissey MA, Funakoshi S, Kreindler JL, Lynch JP. Ectopic Cdx2 expression in murine esophagus models an intermediate stage in the emergence of Barrett’s esophagus. PLoS One. 2011;6:e18280.PubMedPubMedCentralCrossRef
122.
Kong J, Nakagawa H, Isariyawongse BK, et al. Induction of intestinalization in human esophageal keratinocytes is a multistep process. Carcinogenesis. 2009;30:122–130.PubMedCrossRef
123.
Milano F, Van Baal JW, Buttar NS, et al. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology. 2007;132:2412–2421.PubMedCrossRef
124.
Liu T, Zhang X, So CK, et al. Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. Carcinogenesis. 2007;28:488–496.PubMedCrossRef
125.
Stairs DB, Nakagawa H, Klein-Szanto A, et al. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett’s esophagus. PLoS One. 2008;3:e3534.PubMedPubMedCentralCrossRef
126.
Vega ME, Giroux V, Natsuizaka M, et al. Inhibition of Notch signaling enhances transdifferentiation of the esophageal squamous epithelium towards a Barrett’s-like metaplasia via KLF4. Cell Cycle. 2014;13:3857–3866.PubMedCrossRef
127.
Coad RA, Woodman AC, Warner PJ, Barr H, Wright NA, Shepherd NA. On the histogenesis of Barrett’s oesophagus and its associated squamous islands: a three-dimensional study of their morphological relationship with native oesophageal gland ducts. J Pathol. 2005;206:388–394.PubMedCrossRef
128.
Li H, Walsh TN, O’Dowd G, Gillen P, Byrne PJ, Hennessy TP. Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett’s esophagus. Surgery. 1994;115:176–181.PubMed
129.
Garman KS, Kruger L, Thomas S, et al. Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma. Histopathology. 2015;67:771–782.PubMedPubMedCentralCrossRef
130.
Leedham SJ, Preston SL, McDonald SA, et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett’s oesophagus. Gut. 2008;57:1041–1048.PubMedPubMedCentralCrossRef
131.
Kruger L, Gonzalez LM, Pridgen TA, et al. Ductular and proliferative response of esophageal submucosal glands in a porcine model of esophageal injury and repair. Am J Physiol Gastrointest Liver Physiol. 2017;313:G180–G191.PubMedCrossRefPubMedCentral
132.
von Furstenberg RJ, Li J, Stolarchuk C, et al. Porcine esophageal submucosal gland culture model shows capacity for proliferation and differentiation. Cell Mol Gastroenterol Hepatol. 2017;4:385–404.CrossRef
133.
Sarosi G, Brown G, Jaiswal K, et al. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett’s esophagus. Dis Esophagus. 2008;21:43–50.PubMedCrossRef
134.
McDonald SA, Lavery D, Wright NA, Jansen M. Barrett oesophagus: lessons on its origins from the lesion itself. Nat Rev Gastroenterol Hepatol. 2015;12:50–60.PubMedCrossRef
135.
Lavery DL, Nicholson AM, Poulsom R, et al. The stem cell organisation, and the proliferative and gene expression profile of Barrett’s epithelium, replicates pyloric-type gastric glands. Gut. 2014;63:1854–1863.PubMedPubMedCentralCrossRef
136.
Jiang M, Li H, Zhang Y, et al. Transitional basal cells at the squamous-columnar junction generate Barrett’s oesophagus. Nature. 2017;550:529–533.PubMedPubMedCentralCrossRef
137.
Jin RU, Mills JC. Congenital and acquired diseases of the stomach. In: Translational Research and Discovery in Gastroenterology: Organogenesis to Disease, 1st edition. 2014.
138.
Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16:351–380.PubMedCrossRef
139.
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–6740.PubMed
140.
Willet SG, Mills JC. Stomach Organ and Cell Lineage Differentiation: from Embryogenesis to Adult Homeostasis. Cell Mol Gastroenterol Hepatol. 2016;2:546–559.PubMedPubMedCentralCrossRef
141.
142.
McCracken KW, Catá EM, Crawford CM, et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature. 2014;516:400–404.PubMedPubMedCentralCrossRef
143.
Thompson CA, DeLaForest A, Battle MA. Patterning the gastrointestinal epithelium to confer regional-specific functions. Dev Biol. 2018;435:839–843.CrossRef
144.
Mutoh H, Hakamata Y, Sato K, et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun. 2002;294:470–479.PubMedCrossRef
145.
Grainger S, Savory JG, Lohnes D. Cdx2 regulates patterning of the intestinal epithelium. Dev Biol. 2010;339:155–165.PubMedCrossRef
146.
147.
Kuo CT, Morrisey EE, Anandappa R, et al. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 1997;11:1048–1060.PubMedCrossRef
148.
Molkentin JD, Lin Q, Duncan SA, Olson EN. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997;11:1061–1072.PubMedCrossRef
149.
150.
Bosse T, Piaseckyj CM, Burghard E, et al. Gata4 is essential for the maintenance of jejunal-ileal identities in the adult mouse small intestine. Mol Cell Biol. 2006;26:9060–9070.PubMedPubMedCentralCrossRef
151.
Jacobsen CM, Mannisto S, Porter‐Tinge S, et al. GATA-4:FOG interactions regulate gastric epithelial development in the mouse. Dev Dyn. 2005;234:355–362.PubMedCrossRef
152.
Jacobsen CM, Narita N, Bielinska M, et al. Genetic mosaic analysis reveals that GATA-4 is required for proper differentiation of mouse gastric epithelium. Dev Biol. 2002;241:34–46.PubMedCrossRef
153.
Duncan SA, Manova K, Chen WS, et al. Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc Natl Acad Sci U S A. 1994;91:7598–7602.PubMedPubMedCentralCrossRef
154.
Offield MF, Jetton TL, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development. 1996;122:983–995.PubMed
155.
Larsson LI, Madsen OD, Serup P, Jonsson J, Edlund H. Pancreatic-duodenal homeobox 1 -role in gastric endocrine patterning. Mech Dev. 1996;60:175–184.PubMedCrossRef
156.
Holland AM, Garcia S, Naselli G, MacDonald RJ, Harrison LC. The Parahox gene Pdx1 is required to maintain positional identity in the adult foregut. Int J Dev Biol. 2013;57:391–398.PubMedCrossRef
157.
Verzi MP, Stanfel MN, Moses KA, et al. Role of the homeodomain transcription factor Bapx1 in mouse distal stomach development. Gastroenterology. 2009;136:1701–1710.PubMedPubMedCentralCrossRef
158.
159.
Udager AM, Prakash A, Saenz DA, et al. Proper development of the outer longitudinal smooth muscle of the mouse pylorus requires Nkx2-5 and Gata3. Gastroenterology. 2014;146:157–165.PubMedCrossRef
160.
Prakash A, Udager AM, Saenz DA, Gumucio DL. Roles for Nkx2-5 and Gata3 in the ontogeny of the murine smooth muscle gastric ligaments. Am J Physiol Gastrointest Liver Physiol. 2014;307:G430–G436.PubMedPubMedCentralCrossRef
161.
Merchant JL. Hedgehog signalling in gut development, physiology and cancer. J Physiol. 2012;590:421–432.PubMedCrossRef
162.
Merchant JL, Ding L. Hedgehog signaling links chronic inflammation to gastric cancer precursor lesions. Cell Mol Gastroenterol Hepatol. 2017;3:201–210.PubMedPubMedCentralCrossRef
163.
164.
Ramalho-Santos M, Melton DA, McMahon AP. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development. 2000;127:2763–2772.PubMed
165.
Mao J, Kim BM, Rajurkar M, Shivdasani RA, McMahon AP. Hedgehog signaling controls mesenchymal growth in the developing mammalian digestive tract. Development. 2010;137:1721–1729.PubMedPubMedCentralCrossRef
166.
Aubin J, Déry U, Lemieux M, Chailler P, Jeannotte L. Stomach regional specification requires Hoxa5-driven mesenchymal-epithelial signaling. Development. 2002;129:4075–4087.PubMed
167.
Haumaitre C, Barbacci E, Jenny M, Ott MO, Gradwohl G, Cereghini S. Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc Natl Acad Sci U S A. 2005;102:1490–1495.PubMedPubMedCentralCrossRef
168.
Kim SK, Hebrok M, Li E, et al. Activin receptor patterning of foregut organogenesis. Genes Dev. 2000;14:1866–1871.PubMedPubMedCentral
169.
Spencer-Dene B, Sala FG, Bellusci B, Gschmeissner S, Stamp G, Dickson C. Stomach development is dependent on fibroblast growth factor 10/fibroblast growth factor receptor 2b-mediated signaling. Gastroenterology. 2006;130:1233–1244.PubMedCrossRef
170.
171.
Ye W, Takabayashi H, Yang Y, et al. Regulation of gastric Lgr5 + ve cell homeostasis by bone morphogenetic protein (BMP) signaling and inflammatory stimuli. Cell Mol Gastroenterol Hepatol. 2018;5:523–538.PubMedPubMedCentralCrossRef
172.
Shinohara M, Mao M, Keeley TM, et al. Bone morphogenetic protein signaling regulates gastric epithelial cell development and proliferation in mice. Gastroenterology. 2010;139:2050–2060.PubMedPubMedCentralCrossRef
173.
Huh WJ, Mysorekar IU, Mills JC. Inducible activation of Cre recombinase in adult mice causes gastric epithelial atrophy, metaplasia, and regenerative changes in the absence of “floxed” alleles. Am J Physiol Gastrointest Liver Physiol. 2010;299:G368–G380.PubMedCrossRef
174.
Frankfurt OS. Cell proliferation and differentiation in the squamous epithelium of the forestomach of the mouse. Exp Cell Res. 1967;46:603–606.PubMedCrossRef
175.
Karam S, Leblond CP. Origin and migratory pathways of the eleven epithelial cell types present in the body of the mouse stomach. Microsc Res Tech. 1995;31:193–214.PubMedCrossRef
176.
Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. I. Identification of proliferative cell types and pinpointing of the stem cell. Anat Rec. 1993;236:259–279.PubMedCrossRef
177.
Karam SM, Straiton T, Hassan WM, Leblond CP. Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells. 2003;21:322–336.PubMedCrossRef
178.
Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. II. Outward migration of pit cells. Anat Rec. 1993;236:280–296.PubMedCrossRef
179.
Karam SM. Dynamics of epithelial cells in the corpus of the mouse stomach. IV. Bidirectional migration of parietal cells ending in their gradual degeneration and loss. Anat Rec. 1993;236:314–332.PubMedCrossRef
180.
Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. III. Inward migration of neck cells followed by progressive transformation into zymogenic cells. Anat Rec. 1993;236:297–313.PubMedCrossRef
181.
Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. V. Behavior of entero-endocrine and caveolated cells: general conclusions on cell kinetics in the oxyntic epithelium. Anat Rec. 1993;236:333–340.PubMedCrossRef
182.
Lee ER. Dynamic histology of the antral epithelium in the mouse stomach: III. Ultrastructure and renewal of pit cells. Am J Anat. 1985;172:225–240.PubMedCrossRef
183.
Lee ER, Leblond CP. Dynamic histology of the antral epithelium in the mouse stomach: II. Ultrastructure and renewal of isthmal cells. Am J Anat. 1985;172:205–224.PubMedCrossRef
184.
Lee ER, Leblond CP. Dynamic histology of the antral epithelium in the mouse stomach: IV. Ultrastructure and renewal of gland cells. Am J Anat. 1985;172:241–259.PubMedCrossRef
185.
Nozaki K, Ogawa M, Williams JA, et al. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology. 2008;134:511–522.PubMedCrossRef
186.
Matsuo J, Kimura S, Yamamura A, et al. Identification of stem cells in the epithelium of the stomach corpus and antrum of mice. Gastroenterology. 2017;152:218–231.PubMedCrossRef
187.
Goldenring JR, Nam KT, Wang TC, Mills JC, Wright NA. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer. Gastroenterology. 2010;138:2207–2210.PubMedPubMedCentralCrossRef
188.
Choi E, Hendley AM, Bailey JM, Leach SD, Goldenring JR. Expression of activated Ras in gastric chief cells of mice leads to the full spectrum of metaplastic lineage transitions. Gastroenterology. 2016;150:918–930.PubMedCrossRef
189.
Nam KT, Lee HJ, Mok H, et al. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia. Gastroenterology. 2009;136:1288–1296.PubMedCrossRef
190.
Yoshizawa N, Takenaka Y, Yamaguchi H, et al. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest. 2007;87:1265–1276.PubMedCrossRef
191.
Warson C, Van de Bovenkamp JH, Korteland-Van Male AM, et al. Barrett’s esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Hum Pathol. 2002;33:660–668.PubMedCrossRef
192.
Hanby AM, Jankowski JA, Elia G, Poulsom R, Wright NA. Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett’s metaplasia and the native oesophageal epithelium: delineation of epithelial phenotype. J Pathol. 1994;173:213–219.PubMedCrossRef
193.
Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, Corfield AP. Mucin gene expression in Barrett’s oesophagus: an in situ hybridisation and immunohistochemical study. Gut. 2000;47:753–761.PubMedPubMedCentralCrossRef
194.
Lavery DL, Martinez P, Gay LJ, et al. Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett’s oesophagus. Gut. 2016;65:907–913.PubMedCrossRef
195.
Cotton CC, Wolf WA, Overholt BF, et al. Late recurrence of Barrett’s esophagus after complete eradication of intestinal metaplasia is rare: final report from ablation in intestinal metaplasia containing dysplasia trial. Gastroenterology. 2017;153:681–688.PubMedCrossRefPubMedCentral
196.
Haidry RJ, Butt MA, Dunn JM, et al. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut. 2015;64:1192–1199.PubMedCrossRef
197.
Pavlov K, Meijer C, van den Berg A, Peters FTM, Kruyt FAE, Kleibeuker JH. Embryological signaling pathways in Barrett’s metaplasia development and malignant transformation; mechanisms and therapeutic opportunities. Crit Rev Oncol Hematol. 2014;92:25–37.PubMedCrossRef
198.
Metadaten
Titel
Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett’s Stemming from SPEM
verfasst von
Ramon U. Jin
Jason C. Mills
Publikationsdatum
09.06.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5150-0

Weitere Artikel der Ausgabe 8/2018

Digestive Diseases and Sciences 8/2018 Zur Ausgabe

Review

Clinical Guidelines Update on the Diagnosis and Management of Barrett’s Esophagus

Review

Origins of Metaplasia in Barrett’s Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease?

Review

Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus

Review

Natural History of Barrett’s Esophagus

Review

Screening and Surveillance for Barrett’s Esophagus: Is It Cost-Effective?

Review

Histology of Barrett’s Metaplasia: Do Goblet Cells Matter?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Metformin rückt in den Hintergrund

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

24.04.2024 | DGIM 2024 | Nachrichten

Bei Senioren mit Prostatakarzinom auf Anämie achten!
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise